Simon Berry, North East based optometrist, has invented a simple, yet effective way to make eye tests less frightening and intimidating for those with learning difficulties.
Working with Durham University, Simon Berry has created the Visual Fixation System (VFS), which allows patients to watch a video while their eyes are being tested. The VFS is currently being trialled at Aston University, Cardiff University, Association of British Dispensing Opticians, and SeeAbility. Later in the year Simon will visit Great Ormond Street Hospital where trials will continue.
For many children with learning disabilities, a trip to the opticians can be stressful, but this invention gives them a chance to watch their favourite video while having their eyes tested. The VFS works by splitting a beam of light reflecting the image from a phone to the patient, allowing the optometrist to examine their eyes.
Simon Berry has been an optometrist for over 20 years and has worked in hospital paediatric clinics throughout his professional career. Over 16 years ago, he set up his own independent optometry practice in Gilesgate, Durham and he also works at Sunderland Eye Infirmary as a specialist Optometrist. Last month, Simon appeared on BBC’s Look North discussing the success of the device and his plans to take it nationwide.
Simon sees a lot of children and adults with learning disabilities and keeping these patients engaged whilst trying to complete the various clinical measurements required can be challenging. Examinations of such patients are very important, as those with learning disabilities have an increased risk of eye problems, with one in ten having an eye disease and 40% will need glasses.
Simon has been working on the device for over three years and hopes it will help a wide range of patients. In particular, it has been used on Autistic patients who may find eye contact uncomfortable, as it hides the Optometrist’s face as they complete the test. It is also useful for young children and babies who find it hard to sit still, and he predicts it will be useful for patients with dementia, too.